Cargando…
Hippo-YAP1 Is a Prognosis Marker and Potentially Targetable Pathway in Advanced Gallbladder Cancer
Gallbladder cancer is an aggressive disease with late diagnosis and no efficacious treatment. The Hippo-Yes-associated protein 1 (YAP1) signaling pathway has emerged as a target for the development of new therapeutic interventions in cancers. However, the role of the Hippo-targeted therapy has not b...
Autores principales: | García, Patricia, Rosa, Lorena, Vargas, Sergio, Weber, Helga, Espinoza, Jaime A., Suárez, Felipe, Romero-Calvo, Isabel, Elgueta, Nicole, Rivera, Vanessa, Nervi, Bruno, Obreque, Javiera, Leal, Pamela, Viñuela, Eduardo, Aguayo, Gloria, Muñiz, Sabrina, Sagredo, Alfredo, Roa, Juan C., Bizama, Carolina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226626/ https://www.ncbi.nlm.nih.gov/pubmed/32218280 http://dx.doi.org/10.3390/cancers12040778 |
Ejemplares similares
-
A Novel Gemcitabine-Resistant Gallbladder Cancer Model Provides Insights into Molecular Changes Occurring during Acquired Resistance
por: Vergara-Gómez, Luis, et al.
Publicado: (2023) -
Rapamycin and WYE-354 suppress human gallbladder cancer xenografts in mice
por: Weber, Helga, et al.
Publicado: (2015) -
Advances towards the use of gastrointestinal tumor patient-derived organoids as a therapeutic decision-making tool
por: Obreque, Javiera, et al.
Publicado: (2023) -
YAP and the Hippo pathway in cholangiocarcinoma
por: Sugihara, Takaaki, et al.
Publicado: (2019) -
Hippo-YAP/TAZ signaling in angiogenesis
por: Park, Jeong Ae, et al.
Publicado: (2018)